Article metrics

Download PDFPDF

435 A phase II trial of nivolumab plus axitinib in patients with anti-PD1 refractory advanced melanoma

 

Online download statistics by month:

Online download statistics by month: November 2020 to June 2025

AbstractFullPdf
Nov 2020136015
Dec 20202407
Jan 20212200
Feb 20212807
Mar 20217406
Apr 20215007
May 2021603
Jun 2021003
Jul 2021005
Aug 2021007
Sep 2021005
Oct 202132022
Nov 202152015
Dec 20211402
Jan 2022601
Feb 20222602
Mar 20221008
Apr 20224404
May 20222200
Jun 20224203
Jul 20222601
Aug 20222206
Sep 20221201
Oct 20221601
Nov 20221603
Dec 20222803
Jan 20232201
Feb 20232004
Mar 20231603
Apr 20231801
May 20231600
Jun 20231204
Jul 20231004
Aug 20231001
Sep 20232400
Oct 20233603
Nov 20233604
Dec 20233401
Jan 20242404
Feb 20242600
Mar 20242801
Apr 20242201
May 20242800
Jun 20242001
Jul 20241801
Aug 20241600
Sep 20241804
Oct 202444011
Nov 20243607
Dec 20242007
Jan 20252204
Feb 2025001
Mar 2025001
Apr 2025008
May 2025007
Jun 2025004
Total12840225